ShearWave™ Elastography BE1 Multinational Breast Study: Additional SWE™ Features Support Potential to Downgrade BI-RADS®-3 Lesions
Schäfer F, Hooley R, Ohlinger R, Hahne U, Madjar H, Svensson W, Balu-Maestro C, Juhan V, Athanasiou A, Mundinger A, Order B, Locatelli M, Cosgrove D, Wolf O, Henry J, Moutfi M, Gay J, Cohen-Bacrie C. ShearWave™ Elastography BE1 Multinational Breast Study: Additional SWE™ Features Support Potential to Downgrade BI-RADS®-3 Lesions. Ultraschall In Der Medizin - European Journal Of Ultrasound 2013, 34: 254-259. PMID: 23709241, DOI: 10.1055/s-0033-1335523.Peer-Reviewed Original ResearchConceptsMalignancy rateNon-significant increaseLesion groupBI-RADSProspective study populationSWE featuresNumber of lesionsCore biopsyCancer ratesStudy populationLesionsSWE assessmentBenign massesBreast lesionsDiagnostic populationBreast studiesLower increaseUltrasound characterizationE-colorBiopsyMalignancyPopulationShearWaveCytology